Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis

被引：0
|
作者：
Setoguchi, Soko
Solomon, Daniel H.
Weinblatt, Michael E.
Katz, Jeffrey N.
Avorn, Jerry
Glynn, Robert J.
Francis Cook, E.
Carney, Greg
Schneeweiss, Sebastian
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA
[2] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2006年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
039
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Cook, E. Francis
    Carney, Greg
    Schneeweiss, Sebastian
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2757 - 2764
  • [2] Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
    Setoguchi, Soko
    Schneeweiss, Sebastian
    Avorn, Jerry
    Katz, Jeffrey N.
    Weinblatt, Michael E.
    Levin, Raisa
    Solomon, Daniel H.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (02) : 336 - 341
  • [3] Tumor Necrosis Factor- Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Solomon, Daniel H.
    Schneeweiss, Sebastian
    Danaei, Goodarz
    Liao, Katherine P.
    Kim, Seoyoung C.
    [J]. EPIDEMIOLOGY, 2016, 27 (03) : 414 - 422
  • [4] Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis
    L. V. Kozlovskaya
    N. A. Mukhin
    V. V. Rameev
    I. A. Sarkisova
    O. I. Epstein
    [J]. Bulletin of Experimental Biology and Medicine, 2003, 135 (Suppl 7) : 152 - 154
  • [5] Tumor necrosis factor-α blockade in the treatment of rheumatoid arthritis
    Keystone, EC
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2001, 27 (02) : 427 - 443
  • [6] Tumor Necrosis Factor-α Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis
    Bili, Androniki
    Morris, Stephanie J.
    Sartorius, Jennifer A.
    Kirchner, H. Les
    Antohe, Jana L.
    Dancea, Sorina
    Wasko, Mary Chester
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (05) : 946 - 948
  • [7] Tumor necrosis factor antagonists and cancer in patients with rheumatoid arthritis
    Eric L Matteson
    Tim Bongartz
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 14 - 15
  • [8] Tumor necrosis factor antagonists and cancer in patients with rheumatoid arthritis
    Matteson, Eric L.
    Bongartz, Tim
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (01): : 14 - 15
  • [9] Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Rao, Jaya K.
    Hansen, Richard A.
    Fang, Gang
    Maciejewski, Matthew L.
    Farley, Joel F.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (11): : 1110 - 1120
  • [10] Tumor necrosis factor-α microsatellite polymorphism association with rheumatoid arthritis in Indian patients
    Agrawal, C
    Raghav, SK
    Gupta, B
    Das, RH
    Chaturvedi, VP
    Goswami, K
    Das, HR
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (05) : 555 - 559
12345